HomeRGRX • OTCMKTS
add
RegeneRx Biopharmaceuticals Inc
Previous close
$0.00020
Market cap
300.00 USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 76.76K | 0.00% |
Operating expense | 1.48M | 5.73% |
Net income | -1.73M | -8.12% |
Net profit margin | -2.25K | -8.12% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 290.89K | -76.38% |
Total assets | 382.18K | -70.26% |
Total liabilities | 3.83M | 8.90% |
Total equity | -3.45M | — |
Shares outstanding | 1.44M | — |
Price to book | -0.00 | — |
Return on assets | -105.12% | — |
Return on capital | 57.19% | — |
Cash Flow
Net change in cash
| (USD) | 2022info | Y/Y change |
|---|---|---|
Net income | -1.73M | -8.12% |
Cash from operations | -940.72K | 5.01% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -940.72K | -217.05% |
Free cash flow | -455.84K | 13.73% |
About
Founded
1982
Headquarters
Website
Employees
3
